Total epinephrine dose during asystole and pulseless electrical activity cardiac arrests is associated with unfavourable functional outcome and increased in-hospital mortality

Resuscitation

Volumn 83, Issue 3, 2012, Pages 333-337

  Arrich, Jasmin ^a   Sterz, Fritz ^a   Herkner, Harald ^a   Testori, Christoph ^a   Behringer, Wilhelm ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Advanced cardiac life support; Cardiopulmonary resuscitation; Epinephrine; Heart arrest; Mortality; Rehabilitation; Therapy

Indexed keywords

ADRENALIN;

AORTA ARCH SYNDROME; ARTICLE; ASYSTOLE; ELECTRIC ACTIVITY; EMERGENCY WARD; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EPINEPHRINE; FEMALE; HEART ARREST; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84857057279     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.10.027     Document Type: Article

References (20)

1. Rea T.D., Eisenberg M.S., Becker L.J., Murray J.A., Hearne T. Temporal trends in sudden cardiac arrest: a 25-year emergency medical services perspective. Circulation 2003, 107:2780-2785.
2. Gwinnutt C.L., Columb M., Harris R. Outcome after cardiac arrest in adults in UK hospitals: effect of the 1997 guidelines. Resuscitation 2000, 47:125-135.
3. Skrifvars M.B., Vayrynen T., Kuisma M., et al. Comparison of Helsinki and European Resuscitation Council " do not attempt to resuscitate" guidelines, and a termination of resuscitation clinical prediction rule for out-of-hospital cardiac arrest patients found in asystole or pulseless electrical activity. Resuscitation 2010, 81:679-684.
4. Olasveengen T.M., Sunde K., Brunborg C., Thowsen J., Steen P.A., Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 2009, 302:2222-2229.
5. Nolan J.P., Deakin C.D., Soar J., Bottiger B.W., Smith G. European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support. Resuscitation 2005, 67(Suppl. 1):S39-S86.
6. Behringer W., Kittler H., Sterz F., et al. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Ann Intern Med 1998, 129:450-456.
7. Handley A.J., Koster R., Monsieurs K., Perkins G.D., Davies S., Bossaert L. European Resuscitation Council guidelines for resuscitation 2005. Section 2. Adult basic life support and use of automated external defibrillators. Resuscitation 2005, 67(Suppl. 1):S7-S23.
8. Deakin C.D., Nolan J.P. European Resuscitation Council guidelines for resuscitation 2005. Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing. Resuscitation 2005, 67(Suppl. 1):S25-S37.
9. Jacobs I., Nadkarni V., Bahr J., et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa). Resuscitation 2004, 63:233-249.
10. A randomized clinical study of cardiopulmonary-cerebral resuscitation: design, methods, and patient characteristics. Am J Emerg Med 1986, 4:72-86.
11. Lipman J., Wilson W., Kobilski S., et al. High-dose adrenaline in adult in-hospital asystolic cardiopulmonary resuscitation: a double-blind randomised trial. Anaesth Intensive Care 1993, 21:192-196.
12. Lindner K.H., Ahnefeld F.W., Prengel A.W. Comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiol Scand 1991, 35:253-256.
13. Fries M., Weil M.H., Chang Y.T., Castillo C., Tang W. Microcirculation during cardiac arrest and resuscitation. Crit Care Med 2006, 34:S454-S457.
14. Ristagno G., Tang W., Huang L., et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Crit Care Med 2009, 37:1408-1415.
15. Rivers E.P., Wortsman J., Rady M.Y., Blake H.C., McGeorge F.T., Buderer N.M. The effect of the total cumulative epinephrine dose administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest 1994, 106:1499-1507.
16. Tang W., Weil M.H., Sun S., Noc M., Yang L., Gazmuri R.J. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995, 92:3089-3093.
17. Kitsou V., Xanthos T., Stroumpoulis K., et al. Nitroglycerin and epinephrine improve coronary perfusion pressure in a porcine model of ventricular fibrillation arrest: a pilot study. J Emerg Med 2009, 37:369-375.
18. Bassiakou E., Xanthos T., Koudouna E., et al. Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation. Am J Emerg Med 2008, 26:578-584.
19. Huang L., Weil M.H., Sun S., Tang W., Fang X. Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation. J Cardiovasc Pharmacol Ther 2005, 10:113-120.
20. Pellis T., Weil M.H., Tang W., et al. Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation 2003, 108:2716-2721.